Skip to main content

Table 1 Ages of patients who underwent cytology alone, HR-HPV testing alone, and co-testing prior to the diagnoses of CIN1, CIN2/3, and ICC

From: Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

Screening modality CIN1 CIN2/3 ICC
No. (%) Age, average (range), y No. (%) Age, average (range), y No. (%) Age, average (range), y
Cytology alone 560 (30.6) 41.0 (18–64) 879 (38.1) 42.5 (16–71) 230 (33.8) 49.0 (27–85)
HR-HPV testing alone 713 (39.0) 41.5 (14–66) 906 (39.2) 41.1 (20–67) 220 (32.4) 47.9 (25–88)
Cytology and HR-HPV co-testing 556 (30.4) 40.4 (17–70) 524 (22.7) 39.8 (18–72) 230 (33.8) 47.9 (28–87)
Total 1829 (100) 41.0 (17–70) 2309 (100) 41.3 (16–72) 680 (100) 48.3 (25–88)
  1. CIN cervical intraepithelial neoplasia, ICC invasive cervical cancer, HR-HPV high-risk human papillomavirus